Essex Bio-Technology

Essex Bio-Technology

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Hong Kong, Hong Kong

About

The the headquarters of this VC is in Hong Kong. The fund is located in Hong Kong, Asia.

The fund typically invests alone. The investors in the following rounds are usually Zhuhai Yisheng Technology, Tianjin Haida Venture Capital Management, GF Qianhe Investment.

The fund typically enters into less than 2 deals annually. Typical investments for this fund are deals in the range of 1 - 5 millions dollars. The most exits for the fund occurred in 2018. In 2018, the fund's activity was at its peak.

Moreover, a start-up needs to be 4-5 years old to get investment from this fund. Shang Gong, MeiraGTx are amongst the various portfolio companies of this fund. The country of its foundation and the country of its most frequent investments doesn't coincide - United States. Besides this, the fund also invested in 1 other country. We can highlight the most popular investment areas for this fund, such as Clinical Trials, Medical Device. In addition, there are 3 more industries where it has achieved success.

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: essextec.com; User name format in descending order of probability: first_initial last, first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

50.0% of cases

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

8.1 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.6 out of 1

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: